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Abstract
Craniofacial prostheses, also known as epistheses, are artificial substi-
tutes for facial defects. The breakthrough for rehabilitation of facial
Philipp A. Federspil
1
defects with implant-retained prostheses came with the development
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of the modern silicones and bone anchorage. Following the discovery
of the osseointegration of titanium in the 1950s, dental implants have Hospital Heidelberg,
Germany beenmadeoftitaniuminthe1960s.In1977,thefirstextraoraltitanium
implantwasinsertedinapatient.Later,varioussolitaryextraoralimplant
systems were developed. Grouped implant systems have also been
developed which may be placed more reliably in areas with low bone
presentation, as in the nasal and orbital region, or the ideally pneuma-
tised mastoid process. Today, even large facial prostheses may be se-
curely retained. The classical atraumatic surgical technique has re-
mained an unchanged prerequisite for successful implantation of any
system. This review outlines the basic principles of osseointegration as
well as the main features of extraoral implantology.
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1 Craniofacial prosthetic
rehabilitation
Defectsordeformitiesintheheadandfacialareaalmost
always lead to a severe emotional burden requiring reha-
bilitation [1]. Here the complex aesthetic units of ear,
noseandorbitalcavityarepredominant.Inprinciple,two
paths can be followed, those of either plastic surgery or
prosthetic rehabilitation. The procedures involved in
plastic surgery are extremely suitable for the correction
of less complex aesthetic units or partial defects of the
ear, nose and orbital cavity. Particularly mobile areas
suchasthelipsaredifficulttobeadequatelytreatedwith
prosthesesandshoulddefinitelybesurgicallyreconstruc-
ted, even if the remaining defect is treated with a pros-
thesis. This may be accompanied by possible visible
traces of flap raising in an adjacent aesthetic unit (donor
site pathology).
Indications for bone-anchored prostheses are (modified
according to [2], [3]):
• the necessity of optimal tumour aftercare, e.g. in the
case of a high risk of recurrence,
• if local or general contraindications concerning proce-
dures of reconstructive surgery exist (e.g. in the case
of severely damaged skin following radiation),
• poor general condition,
• during individual stages in plastic reconstructive sur-
gery (interim prosthesis),
• following failed reconstructive procedures,
• the rejection of reconstructive procedures on the part
of the patient,
• high aesthetic demands,
• the desire for speedy rehabilitation,
• palliatively operated patients.
1.1Materialsforcraniofacialprostheses
Figure 1: Orbital prosthesis made from silicon. Note the thin,
transparent edges.
Following the large number of materials that have been
tried out in the long history of anaplastology [4], as for
example porcelain, natural rubber, gelatine and latex,
two have established themselves: methacrylates and
silicones. Methacrylates have the advantage of being
moredurable,theyare,however,relativelyhard.Silicones,
on the other hand, are both soft and flexible and keep
bodytemperature.Hairandskinfeaturessuchaspigment-
ationscanbeeasilyintroduced(Figure1).Theedgescan
be stretched so thinly as to become transparent. This
enhances camouflage of the prosthesis as the intersec-
tion between the surrounding skin and the prosthesis is
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prostheses of outstanding cosmetic quality [5].
1.2 Methods of retention of craniofacial
prostheses
The anchorage of prostheses can be achieved in four
ways [6]:
• anatomical anchorage (to already existing anatomical
structures such as undercut areas in the cavities of
an orbital defect),
• mechanical anchorage (for example to spectacle
frames),
• chemical anchorage (using adhesives [7])
• surgicalanchorage(e.g.usingsurgicallycreatedreten-
tion elements [8])
Today, surgical anchorage is carried out using skin pen-
etrating osseointegrated titanium implants (Figure 2) on
thebone[1].Ithassupersededsurgicalproceduressuch
as various flaps [9], [10], [11], [12] for the creation of
skin pockets for securing prostheses. Due to the secure
retention, bone anchorage has contributed to a break-
throughinprostheticrehabilitation[2],[13].Thefirstuse
of percutaneous titanium fixtures outside the oral cavity
was by the Oto-Rhino-Laryngologist Anders Tjellstöm in
1977 for a bone-anchored hearing aid [14], and in 1979
for a bone-anchored prosthesis [15]. Nevertheless, still
validindicationsforconservativeretentionstrategiesmay
exist [16].
Figure 2: Implant systems for bone-anchored craniofacial
prostheses. Left: Epitec system, back left: Brånemark system,
back right: ITI system, front: universal plate of the Epiplating
system, right: titanium bone screws with lengths of 4, 5.5 and
7 mm.
Bone anchorage has the following advantages [17]:
• enhanced and reliable retention
• retentionisnotaffectedbyenvironmentalfactors(e.g.
sweating)
• facilitated insertion of the prosthesis into the proper
position by the patient himself
• the convenience of wearing is improved by not using
adhesives and fewer skin occlusions
• theabovementionedthin,transparentedgesofsilicone
prostheses can be maintained longer than with adhe-
sive prostheses.
1.3 Coupling between implant and
prosthesis
Typically, a metal bar is screwed onto the percutaneous
posts onto which the prosthesis can then be clipped
(Figure 3). This procedure has the advantage that the
retentionstrengthcanbeindividuallyadjustedandaltered
by bending the clips. The bar construction, however, re-
quires substantially parallel aligned percutaneous posts
so that the least possible strain occurs. This parallelism
of the posts is never achieved in the orbital area, and not
always in the mastoid. For this reason, with very few ex-
ceptions, bar construction in the nasal and orbital areas
can be regarded as obsolete [18], [19].
The advancement in magnetic connections thus repre-
sents huge progress. They facilitate the cleaning and in-
sertion of the prosthesis by the patient. For this reason
in the nasal and orbital areas magnets (Figure 10) are
used almost exclusively today [20]. With auricular pros-
theses [21] they are used with non-parallel axes (here a
bar construction can not be attached with low stress),
withimplantsthataretooclosetooneandother(distance
of less than 15 mm) or in the case of individual hygiene
problems.ThemagnetsystemTitanmagnetics
®marketed
bythecompanyStecoconsistsofasamariumcobaltcore
(Sm2Co17) which is gastight and completely encased in
titanium and is thus corrosion free [22]. Since the begin-
ning of the nineties they have stood the test in a variety
of configurations. The company Technovent markets an-
othermagnetsystemunderthenameMagna-CapSystem.
With the installation of long percutaneous posts or mag-
nets with correspondingly long levers, the loading force
imposed upon the implants should be gauged exactly in
order to avoid a loosening of the implants as a result of
too strong leverage [23]. This potential overload must
alsobeconsideredwiththealternativeuseofmushroom-
shaped pushbutton systems [24].
2 Bone anchorage –
osseointegration
The Swede Per-Ingvar Brånemark succeeded in the
nineteen fifties in discovering that titanium possesses
an exceedingly high bio-compatibility in bones (and also
in other human tissue) [5]. He coined the term “osseoin-
tegration” [25]. This term was originally histologically on
anopticalmicroscopiclevelanddefinedasdirectcontact
between implant and bone [26]. It was unclear, however,
whether100%bonecontactwasnecessaryforsuccessful
osseointegration [27]. In fact in the case of clinically
successfulimplantsatitanium-bonecontactofonaverage
only 70–80% was found [28]. On an electro-microscopic
levelthereisa20–500nmwideamorphousgapbetween
titanium and bone which is filled with collagens and cal-
cified tissue [29]. A further weak point in the definition
was that it offered no guidance on deciding whether an
implant was clinically osseointegrated or not. Instead
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ZarbandAlbrektsson[30]providedthefollowingcompact
definition: “Osseointegration is a process whereby clinic-
ally asymptomatic rigid fixation of alloplastic materials is
achieved, and maintained, in bone during functional
loading.”
Within the context of physiological bone healing, two
processes play an important part for osseointegration:
osteoinductionandosteoconduction[31].Whatisunder-
stoodbyosteoinductionistheabilitytorecruitundifferen-
tiated mesenchymal cells and to stimulate their differen-
tiation to preosteoblasts. The trauma in the course of a
fracture, just as with the implantation, stimulates the
accordant signalling cascade. This process is probably
more significant for the formation of new bone tissue
than the effect of the already present osteoblasts [32],
[33]. What is understood by the term osteoconduction in
this context is the ability for bone tissue to grow on a
surface [31]. After the osteoinductive signals, sufficient
bloodsupplyandmaterialfactorsplayarolehere.Copper
and silver are, for example, not osteoinductive [34],
however, stainless steel is [35]. It is important to under-
stand that with osseointegration we are not dealing with
a snapshot, but rather with a process. Through develop-
ment and decomposition, constant remodelling takes
place in living bone tissue. According to Frost’s
mechanostat theory, certain bending loading forces are
necessaryforboneformationandconservation[36],[37].
In vivo measurements revealed that functional loading
withimplant-retainedauricularprostheseswithclipreten-
tion lay within the physiological range [23].
Albrektsson et al. [26] named the following important
factors for the long-term stability of the implant:
• biocompatibility of the material
• implant design
• implant surface
• condition of the recipient area
• surgical technique
• type and period of the functional loading
2.1 Implant materials
Since the work done by Brånemark, commercially pure
titanium (c.p.Ti) is the most frequently utilised material
in dental implantology. According to the manufacturer’s
data, this consists of 99.75% titanium and contains
0.05% iron, 0.1% oxygen, 0.03% nitrogen, 0.05% carbon
and 0.012% hydrogen [38].
Titanium was discovered in England in 1791 by William
Gregor. In 1795 the German chemist Heinrich Klaproth
gave the new element the name titanium. It is one of the
transition metals and has the atomic number 22. As an
oxide with a content of 0.56%, titanium is the 9th most
common element in the continental crust of the earth
[39].Usually,however,itisonlypresentinlowconcentra-
tion. It was not until the introduction of the large-scale
reduction of titanium tetrachloride with magnesium by
WilhelmJustinKrollin1946thattitaniumwasdeveloped
for commercial use.
The structure is polycrystalline with randomly ordered
crystals[38].Surfaceoxidationalreadytakesplaceduring
themanufacturingprocessandcleaning.Ofthedifferent
oxidesthatresultfromthis,TiO2,TiO,Ti2O5,titaniumoxide
is the most common. The titanium oxide layer is 5 nm
thick and is the actual point of communication to the
patient. What is special about titanium oxide is that it
belongstothemoststableandcorrosion-resistantmater-
ials. No other metal oxide has such a high dielectric con-
stant which is almost comparable to that of water [38].
As well as titanium, other metals such as, for example,
stainless steel, niobium, a number of titanium alloys, vi-
tallium
®(cobaltchromemolybdenumalloy)andceramics
also exhibit osseointegration.
The term c.p. titanium is now out of date. Today there is
the international norm ISO 5832-2:1999 “lmplants for
surgery-Metallicmaterials–Part2:Unalloyedtitanium”,
whichhasbeenadoptedunchangedastheGermannorm.
According to this norm, after chemical composition 4
grades are identified. Internationally, however, the most
importance is still given to the classification of the
American Society for Testing and Materials (ASTM). The
ASTMspecificationF-67withgrades1–4(Table1)applies
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for pure titanium for use as a surgical implant which,
nevertheless,onlydiffersslightlyfromthequalitiesofthe
ISO norm. The titanium mini-plates from well-known
manufacturers are usually composed as a rule of grade
2–4 pure titanium (see Table 1).
In the case of osteosynthesis, screws or other mechani-
callybondedimplants(e.g.partsoforthopaedicendopros-
theses) the titanium alloy titanium-6aluminium-4vana-
dium (Ti6AI4V) is inserted as a rule. For use as a surgical
implant, the ASTM specification F 136 applies according
to which a thus termed implant may contain, alongside
titanium, 0.25% iron, 0.13% oxygen, 0.05% nitrogen,
0.08% carbon and 0.012% hydrogen, 5.5–6.5% alumini-
um and 3.5–4.5% vanadium. This specification differs
onlyslightlyfromtheinternationalnormISO5832-3:1996
“Implantsforsurgery-Metallicmaterials-Part3:wrought
titanium6-aluminium4-vanadiumalloy”.Inanimalexper-
iments it was possible to demonstrate the osseointegra-
tion of titanium plates [40]. After 8 weeks a bone - screw
contact of 77% in a pig mandible was achieved. Further-
more, a regeneration of bone under the titanium plate
and bone growth on the plate occurred. Following the
craniectomy of human skull previously provided with ti-
tanium mini-plates, it was possible to establish a bone –
screw contact of 69.3% [41], that is to say in the mag-
nitude/range which was also found with successful os-
seointegrated dental implants.
2.2 Surface quality
Most implants have a spiral macrostructure which en-
sures primary stability until osseointegration is accom-
plished. On the surface, however, differing levels of
roughness(Sa)exist,dependingontheimplant[42].Here
4 categories are classified (Table 2). As a rule the abut-
ments and certain experimental polished implants are
smooth. These have proved themselves unfavourable for
osseointegration [42]. The original Brånemark implant
was a turned screw with minimal roughness. These were
regardedasthegoldstandardindentalimplantologyright
up until the mid nineteen nineties [42]. They are still
marketed for the extraoral area as the Vistafix™ system
by the Cochlear company. Moderately rough implants
exhibitedahigherbonereactionthantheminimallyrough
implants [43]. This does not mean, however, that higher
clinical success is thus achieved [42]. In the case of
dental implants over 2.0 µm Sa roughened by plasma
spray, however, a higher peri-implantitis rate could be
observed[44],[45],sothatminimallyormoderatelyrough
implants provide the best results [42]. In dental implan-
tology, implants with a moderately rough surface are
currently being used most frequently [42], whereby here
commercial factors possibly play a role. Current develop-
ments with bioactive surfaces are discussed further be-
low.
Table 2: Classification of surface roughness according to
Sa-values [42].
3 Extraoral implant systems
For many producers, extra-oral application plays a subor-
dinate role to that of dental application. Currently the
market for niche products for extraoral implants is chan-
ging, the result is that at the time of going to press it
cannot be said with any certainty which systems will be
available on the market in the future. The classic Bråne-
mark system (Figure 2) as a solitary screw implant, as
well the large number of analogous systems from the
field of dentistry are collectively referred to here under
the term “solitary implants”. In order to distinguish these
from classic titanium fixtures, the term “grouped im-
plants”forgridandplatesystemshasbeenchosen,which
aresecuredwithseveralsmallerbonescrews.Withthese
systems an implant can also bear several percutaneous
abutments.
3.1 Extraoral systems with “solitary
implants”
3.1.1 Brånemark system
The Brånemark system (Figure 3) was the first implant
system to be used extraorally [14], [15]. The longest and
most extensive experience has been gathered with this
system [46]. Since the introduction of self-tapping im-
plants, the necessity for tapping has ceased [47]. For the
extraoralarea,titaniumscrewsofalengthof3and4mm
(and 5.5 mm) are available. The flange was originally
designed to avoid an intracranial dislocation of the im-
plantduetotrauma.Theflangeisnowavailableinclosed
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Abutments can be held by a special clamp. It must be
understood, however, that the clamp only reduces the
torque by 10 Ncm so that care must be taken not to inad-
vertently overwind the implant. Currently the Brånemark
systemisbeingmarketedbytheCochlearCompanyunder
the brand name Vistafix.
3.1.2 ITI systems
With ITI implants (International Team for Implantology)
marketed by the Straumann company, a sand-blasted,
large grit, acid-etched surface was introduced, the so-
calledSLAsurface.Theresultingroughnessistwo-staged:
the greater roughness of ca. 20 µm is overlaid by a finer
roughnessof2µmintervals[48].Fortheextraoralregion
self-tapping titanium screws with a diameter of 3.3 mm
and a countersunk depth of 3.5 or 5 mm with a coned
seat, as well as with a diameter of 2.5 or 4 mm with
flange(Figure2).Thelongerscrewswhichweredesigned
for the extraoral region are also available with the hydro-
philic SLActive surface.
3.1.3 Other systems with solitary implants
Some systems which were designed for the extraoral re-
gion, as for example the IMZ system [49] marketed by
Friatec (Friadent), or the epiplant system marketed by
Mathys, are no longer on the market. Dentsply Friadent
is currently marketing the Ankylos system. Yet another
company, Southern Implants, is marketing extraoral
screws of grade 4 titanium, as well as dental implants.
3.2 Extraoral systems with grouped
implants
In 1956, Köle and Wirth [50] described subperiosteal
frame implants made of Wisil
®, a cobalt chrome alloy.
These subperiosteal implants were adapted to the bone
surface, without being anchored into the bone itself. The
prosthesis attachment takes place on parts of the frame
implant projecting through the skin. A patient with an
auricularprosthesisandonewithanasalprosthesiswere
treated in this way. Both implants had healed with no
adverse reactions after 8 years [51]. In contrast to this,
the analogous use of subperiosteal implants in the jaw
for fixing dental prostheses was less successful, which
could be put down to the higher mechanical load [51].
Both systems described in the following are also used
subperiosteally, but fixed with bone screws also used in
osteosynthesis (Figure 2). In contrast to the solitary im-
plants, the forces are distributed across the plate over
several titanium bone screws. An already thinned out
area can be used again following the loss of another
(solitary) implant. In this way a secure fixing in anatomi-
cally difficult regions with limited bone area is possible.
3.2.1 Epitec system
TheEpitecsystem,creditedwithbeingdevelopedin1991
by Mostafa Farmand [52] and the company Leibinger,
represents a great advancement. The system consists of
amouldablequadratictitaniumgridwith16threadholes,
the so-called 3D carrier plate, and self-tapping 2 mm ti-
tanium screws which are available in lengths of 4.5 and
6 mm. The 3D carrier plate has to be cut to the required
shape. For reasons of stability, as many connecting
bridges between the single screw holes as possible must
be maintained. Single extensions are not stable. Plate
retentionresultsprimarilyfromtheuseofthesemonocor-
tical bone screws. Secondary to this, the 1 mm thick
connectingbridgesofthe3Dcarrierplatewillbecovered
over by bone. A thinning of the skin is usually not recom-
mended.Duetotheeasypliancy,constructionsextending
into the defect are currently no longer recommended. In
order to screw on the mountings, only a thread height of
1 mm with 2 screw leads is available.
3.2.2 Epiplating system
Figure 4: Examples for the attachment of implants of the
Epiplating system in the auricular, nasal and orbital regions.
The trimmed universal plate in the glabella is only expedient
in the case of resected nasal bones.
The Epiplating system (Figure 4) was developed in 2000
by the Medicon company in collaboration with P. Feder-
spil, Ph.A. Federspil and M. Schneider [53]. It is the ad-
aptation of the 2.0 titanium mini-plate system produced
byMediconandusedintraumatologytotherequirements
ofanaplastology.Speciallyadaptedimplantsareavailable
for the auricular, orbital and nasal regions, as well as a
universal plate. The titanium plates of the Epiplating
system are 1 mm thick, but 2 mm in width and are thus
stronger than the Epitec grid system. In the area of the
tapped holes provided for the mountings, the thickness
oftheplateis2mm,appropriatefor4threadturns,which
counterbalances any tendency of loosening of the percu-
taneous base posts or magnets. To anchor the plates, ti-
tanium screws of 2 mm in breadth are used which are
supplied as standard in the following lengths: 4, 5.5 and
7mm.Thusthehighstabilityknownfromplateosteosyn-
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holds the subcutaneous tissue still to be excised. A thin periosteal layer remains. On both Brånemark implants for auricular
prosthesis the insertion posts have not yet been unscrewed. Further occipitally, a Brånemark implant for a bone-anchored
hearingaidhasbeeninserted.b)Thesubcutaneoustissueisresected.c)Thesplitskinflapisfoldedbackandsewnin.Abutments
are screwed on. Any remnant of the auricle is removed. d) The split skin is packed under the healing cap.
thesis can be achieved. At the same time, the plates are
moreresistantagainstrotationalforceswhichoccurwhen
screwingdownandunscrewingthemountings.Acounter
instrument such as this as is usual in solitary implants
does therefore not have to be used. Magnets can either
be screwed directly into the plate or onto a base posts,
as the height of the mounting requires. In addition, the
Epiplating system can be combined with the hearing
device abutment of the BAHA system [53], [54].
4 Implantation
4.1 Main features of the surgical
technique
The basic principles of the surgical technique all date
fromtheBrånemarktechnique.Basicallywecandifferen-
tiatebetween2stages:thefirststageconsistsinessence
of bone drilling and the insetting of the titanium implant.
The second stage consists of the soft tissue reduction
and achieving a hairfree surrounding skin areal, as well
as the insertion of the percutaneous abutment through
the skin. Both these steps can be carried out either in
one operation (one-staged), or in two separate interven-
tions (two-staged). In order to minimise the surgical
trauma for the bone, the following points are of impor-
tance:
• The use of a new and sharp drill / cutting burr
• Low drill speed (1500–2000 Rpm)
• Extensive cooling through flushing with Ringer’s solu-
tion
The surgical technique varies for solitary and grouped
implant systems.
4.1.1 Surgical technique with solitary implant
systems
In the past a thread had to be cut into the bone for im-
plantation. Today, self-tapping titanium screws are avail-
able for all established systems. Special instruments are
required. Palpating movements with the drill indicate
whether there is still bone at the bottom of the hole. In
order to avoid contamination, the titanium fixture should
only be handled with titanium instruments. With torque
control, the titanium fixture is screwed in mechanically
withnomorethan10–45Ncm.Theuseofthe4mmlong
fixturesispreferred.Theskinthinningintheareaaround
the titanium screw prevents pocket formation and skin
movements around the implant which might lead to in-
flammation (Figure 5a-b). An attachment (called either
percutaneous post or abutment) is screwed onto the ti-
tanium implant itself which then projects outwards
throughtheskin(Figure5c).Agauzestrippackingpresses
the thinned skin to the periosteum (Figure 5d). With non-
irradiated adults and a cortical bone thickness of 3mm,
one-stagedimplantationispossible.Theunloadedhealing
phaseis6weeks.Otherwisetwo-stagedprocedureshould
be initiated at intervals of 3 months. With irradiated pa-
tients, an interval of 6 months should pass before the
second stage.
4.1.2Surgicaltechniquewithgroupedimplant
systems
With grouped implant systems, instruments are predom-
inantly used which are common in osteosynthesis. In
addition,onlyafewspecialinstrumentsarerequired.The
implants are inserted subperiosteally (Figure 6). It is im-
portant to fit the implants as level as possible to the
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periosteum could be preserved. c) Subperiostal positioning of an Epiplating auricular plate. Parotidectomy and neck dissection
have been performed. d) The periostal flap is folded back and perforated in the area of the tapped holes. e) A split thickness
skin transplant is covering the periosteum.
Figure 7: a) Patient from Fig. 6. three years after surgery. b) With 3 year-old auricular prosthesis (Epitheseninstitut Schneider).
shape of the bone using bending pliers. This avoids ten-
sion on the plate. Before bending the grid or the plate,
threads are secured by cover screws in order to avoid
anydistortion.Holesaredrilledfortheself-tappingtitani-
um bone screws using a spiral drill (1.6 mm diameter).
The atraumatic principles of implantology referred to
above remain valid. At least 3 (4 would be better) screws
should be inserted in order to achieve primary stability.
Overwinding the screws must be avoided. The percu-
taneous passage with the abutment/magnet can be
carried out directly in the area of a tapped hole in the
plate (Figure 7). There is also the possibility, however,
that skin penetration takes place at the back bone of the
plate (e.g. nasal plate of the Epiplating system) outwards
through the skin (Figure 9). The management of soft tis-
sue is just as important as the implantation, but soft tis-
suereductiondoesnothavetobecarriedoutasradically
asisthecasewiththeBrånemarktechnique.Onprinciple,
an integration phase of 2 to 3 months is recommended.
Under ideal circumstances, loading is also possible after
6 weeks.
4.2 Contraindications
Absolutecontraindicationswithregardtoanimplantation
are severe psychiatric disorders (e.g. dementia) and
cachexia.Alackofhygiene,drugoralcoholaddictionand
minor psychiatric disorders are merely relative contrain-
dications and should be assessed individually.
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regionally specific characteristics
The locations for percutaneous mountings should first
and foremost correspond to the requirements of the
anaplastologist. The bone is only of secondary impor-
tance.Whilstwithsolitarysystemsimplantationareaand
thatoftheabutmentareidentical,thiscanbevariedwith
grouped implant systems subject to the bone availability.
Apart from standard situations, it is advisable to discuss
theoptimalregionfortheabutmentwiththeanaplastolo-
gist before the procedure. This is also the case for the
number of abutments or magnets required in individual
cases. At the same time, a basis for trust is established
between the anaplastologist and the patient which also
helpstodissipateunrealexpectations.Onevaluablegain
is the presence of the anaplastologist in the operating
theatre.
4.3.1 Ear
Figure 8: The ideal position for a structure for securing an
auricular prosthesis on the right is marked in green. The
distance to the centre of the auditory canal is 2 cm.
If the dial of a watch was to be projected onto the right
ear, the classic regions for implantation would be eight
o’clock or, even better, 9 o’clock, as well as between 10
and 11 o’clock at a distance of 2 cm from the external
earcanal(Figure8).Thislocalisationcorrespondsroughly
withtheanthelixandthusallowsasufficientlyhighspace
for the abutment of the auricular prosthesis. Two abut-
ments are sufficient for a bar construction. When using
magnets, a third magnet can improve retention. This is
then usually placed caudally from seven to eight o’clock.
If 3 magnets are used, they should preferably not be in
a straight line. Any remnants of the auricle still present
should,asarule,beremoved.Inanidealpneumatisation
the cortical bone in adults is partially only 1–2 mm thick.
In this case grouped implant systems have particular
advantages. As well as the classic auricular plate with 2
tappedholeswiththeEpiplatingsystem,anewplatewith
3 tapped holes is also available. The optimum distance
of 1.5 cm between the magnets is, in the case of the
Epiplating auricular plate, already taken into account.
When using an Epitec grid, however, these points must
be borne in mind during planning.
4.3.2 Nose
Due to the limited amount of bone available, the use of
solitary implants in the nasal region is problematic.
Provided that the nasal bone is completely removed,
sufficientbonecanbefoundaroundtheglabella.Anchor-
ing a nasal prosthesis to a solitary Brånemark implant in
the glabella is possible. Otherwise solitary implants can
beusedsolelyatthenasalfloorwhich,however,provides
less a secure retention for the prosthesis. Good bone
availability for the use of the Epiplating system can be
found around the piriform aperture, and in particular at
the frontal process of the maxilla (Figure 9, Figure 10).
Inaddition,auniversalplateoftheEpiplatingsystemcan
be implanted in the glabella (Figure 4).
Figure9:a)67year-oldpatientwithasquamouscellcarcinoma
of the inner nose. Recurrence after primary radiotherapy 1
year earlier. b) The CT shows widespread infiltration. c)
Intra-operative situation following tumour resection. d) An
Epiplatingnasalplateisinsertedontheright.Thetappedholes
are secured with blue covering screws. Open wound areas are
covered with split thickness skin transplants.
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implant is stable with no adverse skin reactions and is fitted
with 2 magnet inserts (Steco). b) Patient with the
bone-anchorednasalprosthesis(EpitheseninstitutSchneider).
4.3.3 Orbital cavity
Figure 11: a) The ideal positions for implant placement for
orbital prostheses are marked in green. b) Classic positioning
ofanorbitalplatefor2magnets(cranial)and1universalplate
(caudal). The long eyelets of the orbital plate have been
removed here. 4 arms were used form the universal plate. c)
For smaller orbital defects, one magnet above and below is
sufficient. Here an orbital plate was inserted in two halves. d)
Other combinations are possible, here, for example, a halved
orbital plate and a universal plate with 2 arms was inserted
above. Below, a universal plate can be seen.
Classicimplantregionsarefoundinthelaterocranialand
laterocaudal orbital rim (Figure 11a). The mediocranial
area is too close to the frontal sinus and the bone in the
mediocaudalareaisusuallytoothin.Nomagnetsshould
be placed laterally as here there is not enough height for
the prosthesis. In the standard situation, an orbital plate
of the Epiplating system can be implanted laterocranially
for 2 magnets, and a universal plate laterocaudally for
one further magnet (Figure 11b, Figure 12, Figure 13).
Inthecaseofasmallorbitalcavity,2magnetsdistributed
laterocranially and laterocaudally on one universal plate
respectively are sufficient. Alternatively an orbital plate
can also be divided and one half each distributed on the
samepositions(Figure11c-d).Inthecaseofaflatorbital
cavity, the Epitec or Epiplating system can be placed
through the orbital cavity like a ladder in the sagittal
plane.Alternatively,theflatorbitalcavitymustbesecond-
arily deepened in order to achieve the necessary height
fortheprosthesisofaround1cm.Thefreetransplantation
of a non-vascularised bone from the iliac crest with the
insertionof2solitaryimplants[55]hasalsobeenreport-
ed.Alternatively,alongsidetheextraoralsolitaryimplants,
the longer dental implants may also be used. Thus
Wächter et al. [56] report on the use of 8, 10 and 12 mm
long ITI titanium screws in the orbital region.
Figure 12: a) 48 year-old patient with a relapsed squamous
cell carcinoma of the ethmoid. The primary tumour had been
resected one year before via medifacial degloving R2. As the
patient had initially refused an orbital exenteration,
chemoradiation (66 Gy) was additionally carried out. b)
Extensive infiltration of the orbital cavity can be seen in the
MRI. c) The resected tumour specimen. d) An orbital plate and
a universal plate are inserted.
4.3.4 Extensive facial defects and special
applications
In the cases of defects that exceed one aesthetic unit,
individual solutions using combinations of several of the
above mentioned implant types have to be found. In the
case of a missing frontal bone the possible solution lies
intheuseofthelongplateoftheEpiplatingsystemwhich
can be laid straight through the orbital cavity from the
glabella to the malar bone (Figure 14). The zygomatic
archcanalsoserveasananchoragepointforauniversal
plate. An accompanying measure is the split skin trans-
plantation, (Figure 6, Figure 9, Figure 13) for a more
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Federspil: Implant-retained craniofacial prostheses for facial ...Figure13:a)PatientfromFig.12.Theimplantshavebeenexposedandtemporarilycoveredwithhealingcapsuntilthemagnets
are screwed on. From this angle the cranial implant is not visible. The split thickness skin graft placed into the cavity has healed
in. b) The patient is wearing the bone-anchored facial prosthesis (Epitheseninstitut Schneider).
Figure 14: a) 49 year-old patient with a fronto-orbital facial defect 3 years after craniofacial resection. b) The bone defect is
recognisable in the CT. The most important anchorage option in the region of the cranial orbital clip is missing. c) The long plate
oftheEpiplatingsystemisfixedsubperiostallyintheregionoftheglabellaandtothemalarbone.Thethreadguidesaresecured
bycoveringscrewsandlieinthecentreoftheorbitalcavity.d)Thewoundisclosed.e)Thehealingprocessiscomplete.Magnets
(Steco) are screwed into the thread guides. f) The patient is provided with a bone-anchored orbital prosthesis (Epitheseninstitut
Schneider). The patient wears glasses for improved camouflage and protection of the right eye.
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multicentre study. The table does not claim to be complete.
speedy tissue repair. Facial prostheses can be coupled
reciprocallywithdefectobturatorprosthesessothatthey
support each other [57].
Exposed nerves or exposed or reconstructed dura mater
at the skull base usually require vascularised covering,
ideally with a microvascular anastomosed free tissue
transfer [58], [59], [60]. Here the required height for the
prosthesis must be observed. If this is not the case, then
the area must be thinned after healing.
4.4 Results of the implantation
By far the greatest experiences have been gathered by
the classic Brånemark system. The best results are
achieved in the mastoid: here the loss rate is only 8%
[46]. On the other hand, a loss of 50% loss of Brånemark
implants in the frontal bone, and 20% in the malar bone
must be reckoned with [46]. These regions, however, are
also more frequently irradiated. Schwipper at al. [61] re-
port a loss rate of around 5.8% in the auricular region,
23.5% in the orbital region, 40% in the nasal region, and
17.4% with combination prostheses. With the author’s
patients the failure rate of Brånemark implants for auri-
cular prostheses was 2.27% [62]. In an US American
multicentre study an implant failure rate in the orbital
region of 23% after 5 years and 42% after 10 years was
found [17]. Table 3 summarise a selection of larger
studies on Brånemark implants classified according to
region and irradiation.
With the Epitec system, Farmand [63] reported the loss
of 4 out of a total of 35 grids (12.5%), which admittedly
camefromtheearlyperiod.Amongsttheauthor’spatients
there was one loss out of 87 implants (1.15%) of the
Epiplating system.
Hereanasalplatewasinvolvedwhichwasplacedonthin
nasal bones. The Epiplating system has also been used
successfully by other authors [54], [64], [65].
4.5 Complications
The most frequent problems come from the site of the
skinpenetration.Inspiteofextensiveskinthinning,some
patients occasionally experience adverse skin reactions.
In comparison to oral implants, there are significant dif-
ferences. The gingiva is made for mucosal penetration.
Saliva and the cleaning properties of the tongue contrib-
ute significantly towards maintaining good condition in
the implant area. Holgers et al. [66] have described a
scoring system for the classification of these skin reac-
tions: 0: no reaction, 1: reddish, 2: red and moist, 3:
granulationtissue,4:skininfectiontosuchadegreethat
theabutmenthastoberemoved.92.5%ofBAHApatients
had a reaction-free periimplant skin (Holger score 0),
91.1% of those wearing an orbital prosthesis and 89.3%
of those with an auricular prosthesis [67]. Important
factors are thinning of the skin and personal hygiene.
Otherwise complications are extremely rare. With their
reportofanintracerebralabscessfollowingthechanging
of a percutaneous abutment in a BAHA patient, Deitmar
et al. [68] described the first serious complication [69]
of an extraoral osseointegrated implant worldwide.
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Granström[70]foundanoverallfailurerateofBrånemark
implants (including dental implants)) of 23.3% with irra-
diatedpatientsascomparedto10.8%withnon-irradiated
patients.Bonesaroundtheorbitalcavityweresignificantly
more affected with a failure rate of 40–50%. Unfavour-
able loading situations due to the prosthetic retention
systemalsohadanunfavourableinfluence.Theinfluence
of the radiation dosage expressed as “cumulative radi-
ation effect” (CRE) according to Kirk et al. [71] became
statisticallysignificantfromvalueof30relatingtoimplant
loss. However, only very few implants were used with
such high CRE values. Traditionally in Sweden many pa-
tientsreceivedradiotherapypre-operativelywiththeresult
that the vast majority of patients were already irradiated
prior to implantation. Following a time period of 15 years
between radiotherapy and implantation, a significantly
higher loss was determined [70]. Hyperfractionation, on
the other hand, had no influence on the survival of the
implant [70]. With a hyperbaric oxygen therapy (HBO) a
loss rate of only 8.5% as opposed to 40.2% without HBO
was achieved [70]. Nevertheless, this procedure is not
without controversy [72]. In a non-randomised US Amer-
icanmulticentrestudytherewasnosignificantdifference
in the survival rate of titanium implants in the orbital
cavity region either with or without HBO [17]. The most
favourableoptioniscertainlytoimplantbeforeradiation;
no HBO therapy would then be necessary. Alternatively
there should be a pause of I year following radiation be-
fore bone anchorage takes place. The author does not
routinely use HBO. The procedure is carried out in two
stages with a healing phase of 6 months.
4.7 Craniofacial prosthetic treatment of
children
The treatment of children and adolescents with bone-
anchored prostheses [21], [46], [73] is also possible.
This question arises most frequently in cases of major
auricular malformations. With children it is important to
beascautiousaspossiblewiththeimplantationasowing
to scar formation the prospects for plastic surgery will at
theveryleastdeteriorate.Inparticularduetotheprogress
made in surgical (re-) construction of the auricle [74],
[75], it is important not to block this option for young pa-
tients. Even after previous surgery, the implantation of a
porous polyethylene framework can be carried out if the
superficial temporal vessels are preserved [76]. If the
socialandemotionalstateofthechildrequiresnourgent
action, any rehabilitation should only be carried out if
young patients have a say in the matter or can decide for
themselves. Proops [77] recommends provision with
bone-anchored prostheses from the age of 10 years. An
implantation should at best only be considered after pu-
bertyinadolescents[78].Atemporarysolutionisoffered
by an adhesive retained prosthesis. In the case of mal-
formations in children it should not be forgotten that the
young patients should indeed be cared for (and not the
parents) and their wishes be respected [79].
5 Current developments
An orbital prosthesis was presented by Klein et al. [80]
which can blink via myoelectric conduction from the op-
posite side. Up until now, however, such prostheses have
been too heavy. A further field where exciting develop-
mentsareawaitedisthatofrobot-supportedinterventions
[81], [82]. First steps have been taken in the area of im-
plantology for bone-anchored prostheses [83].
Bioactive surfaces are on offer from a number of produ-
cers of dental implants [42] which in the advertising are
referredtoas“osteo-attractive”.Inthiscontext,bioactivity
is defined as a “characteristic of an implant material
whichallowsittocultivateaconnectionwithlivingtissue”
[84]. With such bioactive surfaces it is hoped that a
speedier osseointegration will be achieved. Calcium
phosphate bonded implants are available from several
manufacturers [42]. A fluoridated implant (Osseospeed)
is produced by Astra Tech. With TiUnite, Nobel Biocare
offers an implant with an oxidised surface, where in one
studynobioactivitycouldbedemonstrated,however[85].
In the case of an oxidised magnesium implant, on the
other hand, a speedier osseointegration could be ob-
served[86].Onefurtherfieldisthatofthepharmaceutical
coating of implants with, for example, the bone morpho-
genetic protein (BMP), or other bone growth factors. In
animal experiments, a nano-porous TiO2 coating also
proved to be more favourable than standard implants
[69]. Siegert and Stemmann [87] treated patients with
a subcutaneously implanted double magnet, where the
auricular prosthesis attached magnetically can be worn
on intact skin. To what extent these approaches will be
successful and better than previous procedures in the
future still has to be shown by clinical studies.
6 Advantages and disadvantages
of implant-retained prostheses
Implant-retained prostheses have both advantages and
disadvantages (Table 4). In the majority of cases the ad-
vantages prevail. They are not the opposite of plastic re-
constructivemeasures,butcanratherfrequentlybeused
complementarily. They can also be used as a temporary
measure before surgical reconstruction (interim provi-
sion). This would be expedient, for example, in the case
ofadefectafterrhinectomywhencomplexreconstruction
is to be carried out only after a period of 2 years so that
the risk for tumour recurrence is minimal. Here, an im-
plantationwouldnothinderlaterreconstruction.Implant-
retained prostheses are indeed more than just an alter-
native.
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Erratum
The figures 8 and 9 have been renumbered and the fig-
ures12and14havebeenswitched.Thereferences1–20
have been modified. The text has been linguistically im-
proved.
Corresponding author:
Dr. med. Philipp A. Federspil
DepartmentofOto-Rhino-Laryngology,UniversityHospital
Heidelberg, Im Neuenheimer Feld 400, 69120
Heidelberg, Germany, Phone: +49 6221 56-39511 or
-6704, Fax: +49 6221 56-33637
federspil@med.uni-heidelberg.de
Please cite as
Federspil PA. Implant-retained craniofacial prostheses for facial
defects. GMS Curr Top Otorhinolaryngol Head Neck Surg.
2009;8:Doc03.
DOI: 10.3205/cto000055, URN: urn:nbn:de:0183-cto0000556
This article is freely available from
http://www.egms.de/en/journals/cto/2009-8/cto000055.shtml
15/16 GMS Current Topics in Otorhinolaryngology - Head and Neck Surgery 2009, Vol. 8, ISSN 1865-1011
Federspil: Implant-retained craniofacial prostheses for facial ...Published: 2011-03-10
Published with erratum: 2012-03-19
Copyright
©2009 Federspil. This is an Open Access article distributed under the
terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You
are free: to Share — to copy, distribute and transmit the work, provided
the original author and source are credited.
16/16 GMS Current Topics in Otorhinolaryngology - Head and Neck Surgery 2009, Vol. 8, ISSN 1865-1011
Federspil: Implant-retained craniofacial prostheses for facial ...